Clinical trial
Prospective Study Evaluating Clopidogrel Resistance in Ischemic Stroke Patients From Different Ethnicities
NCT03806894 is registered in ClinicalTrials.gov with Ziv Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study Evaluating Clopidogrel Resistance in Ischemic Stroke Patients From Different Ethnicities
- Lead sponsor
- Ziv Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2019
- Completion date
- December 31, 2020
- Enrollment
- 300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
clopidogrel, poor metabolism of, ischemic stroke